HHS will invest $10 billion to ramp up screening testing to help schools reopen and $2.25 billion to scale up testing in underserved populations, and provide new guidance on asymptomatic screening testing in schools, workplaces, and congregate settings.
Read More
The companies’ goal is to improve laboratory workflow/automation for covid-19 testing, sample storage, and biobanking.
Read More
The machine vision-based blood analyzer is part of an assessment of the AI-based ‘CURIAL’ test to rapidly screen for covid-19 in patients arriving in emergency departments.
Read More
Roche Molecular Systems’ cobas SARS-CoV-2 and Influenza A/B Nucleic Acid Test is for use on the cobas Liat System. The false positive results may be related to two issues observed by Roche.
Read More
Researchers have designed a new rapid test that can detect all three of the rapidly spreading variants of covid-19 in a little over one hour.
Read More